| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4117560
[patent_doc_number] => 06046322
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-04
[patent_title] => 'Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5%'
[patent_app_type] => 1
[patent_app_number] => 9/208587
[patent_app_country] => US
[patent_app_date] => 1998-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2148
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/046/06046322.pdf
[firstpage_image] =>[orig_patent_app_number] => 208587
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/208587 | Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5% | Dec 9, 1998 | Issued |
Array
(
[id] => 4190903
[patent_doc_number] => 06153646
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-28
[patent_title] => 'Binuclear platinum complexes, method for preparing same and pharmaceutical compositions containing said complexes'
[patent_app_type] => 1
[patent_app_number] => 9/147015
[patent_app_country] => US
[patent_app_date] => 1998-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5685
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/153/06153646.pdf
[firstpage_image] =>[orig_patent_app_number] => 147015
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/147015 | Binuclear platinum complexes, method for preparing same and pharmaceutical compositions containing said complexes | Dec 8, 1998 | Issued |
| 09/168447 | ORGANIC COMPOUNDS | Oct 7, 1998 | Abandoned |
Array
(
[id] => 3915096
[patent_doc_number] => 06001966
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-14
[patent_title] => 'Method for solution phase synthesis of oligonucleotides and peptides'
[patent_app_type] => 1
[patent_app_number] => 9/130232
[patent_app_country] => US
[patent_app_date] => 1998-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 26100
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/001/06001966.pdf
[firstpage_image] =>[orig_patent_app_number] => 130232
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/130232 | Method for solution phase synthesis of oligonucleotides and peptides | Aug 5, 1998 | Issued |
Array
(
[id] => 4262330
[patent_doc_number] => 06204375
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'Methods and reagents for preserving RNA in cell and tissue samples'
[patent_app_type] => 1
[patent_app_number] => 9/127435
[patent_app_country] => US
[patent_app_date] => 1998-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 16
[patent_no_of_words] => 9395
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/204/06204375.pdf
[firstpage_image] =>[orig_patent_app_number] => 127435
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/127435 | Methods and reagents for preserving RNA in cell and tissue samples | Jul 30, 1998 | Issued |
Array
(
[id] => 4132711
[patent_doc_number] => 06147058
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-14
[patent_title] => '1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine'
[patent_app_type] => 1
[patent_app_number] => 8/973529
[patent_app_country] => US
[patent_app_date] => 1998-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11575
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/147/06147058.pdf
[firstpage_image] =>[orig_patent_app_number] => 973529
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/973529 | 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine | Jun 28, 1998 | Issued |
Array
(
[id] => 3986326
[patent_doc_number] => 05959099
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Protecting group for synthesizing oligonucleotide analogs'
[patent_app_type] => 1
[patent_app_number] => 9/103399
[patent_app_country] => US
[patent_app_date] => 1998-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10618
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 630
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/959/05959099.pdf
[firstpage_image] =>[orig_patent_app_number] => 103399
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/103399 | Protecting group for synthesizing oligonucleotide analogs | Jun 23, 1998 | Issued |
Array
(
[id] => 4219945
[patent_doc_number] => 06040289
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-21
[patent_title] => 'Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds'
[patent_app_type] => 1
[patent_app_number] => 9/077663
[patent_app_country] => US
[patent_app_date] => 1998-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23008
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/040/06040289.pdf
[firstpage_image] =>[orig_patent_app_number] => 077663
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/077663 | Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds | May 28, 1998 | Issued |
Array
(
[id] => 3945858
[patent_doc_number] => 05977086
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Method of inhibiting human immunodeficiency virus by combined use of hydroxyurea, a nucleoside analog, and a protease inhibitor'
[patent_app_type] => 1
[patent_app_number] => 9/056691
[patent_app_country] => US
[patent_app_date] => 1998-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10419
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/977/05977086.pdf
[firstpage_image] =>[orig_patent_app_number] => 056691
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/056691 | Method of inhibiting human immunodeficiency virus by combined use of hydroxyurea, a nucleoside analog, and a protease inhibitor | Apr 7, 1998 | Issued |
Array
(
[id] => 4158982
[patent_doc_number] => 06103892
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Catalyst that oxidizes steroids and other substrates with catalytic turnover'
[patent_app_type] => 1
[patent_app_number] => 9/057417
[patent_app_country] => US
[patent_app_date] => 1998-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 5364
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103892.pdf
[firstpage_image] =>[orig_patent_app_number] => 057417
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/057417 | Catalyst that oxidizes steroids and other substrates with catalytic turnover | Apr 7, 1998 | Issued |
Array
(
[id] => 3946122
[patent_doc_number] => 05998387
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Method for using A.sub.1 adenosine receptor agonists'
[patent_app_type] => 1
[patent_app_number] => 9/056195
[patent_app_country] => US
[patent_app_date] => 1998-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 9
[patent_no_of_words] => 14765
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/998/05998387.pdf
[firstpage_image] =>[orig_patent_app_number] => 056195
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/056195 | Method for using A.sub.1 adenosine receptor agonists | Apr 5, 1998 | Issued |
Array
(
[id] => 4189878
[patent_doc_number] => 06043052
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-28
[patent_title] => 'GPR 25 polynucleotides'
[patent_app_type] => 1
[patent_app_number] => 9/034985
[patent_app_country] => US
[patent_app_date] => 1998-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10665
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/043/06043052.pdf
[firstpage_image] =>[orig_patent_app_number] => 034985
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/034985 | GPR 25 polynucleotides | Mar 3, 1998 | Issued |
Array
(
[id] => 3937286
[patent_doc_number] => 05972905
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Use of oligosaccharides for the treatment of pruritus cutaneus associated with renal failure'
[patent_app_type] => 1
[patent_app_number] => 8/973969
[patent_app_country] => US
[patent_app_date] => 1998-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2242
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972905.pdf
[firstpage_image] =>[orig_patent_app_number] => 973969
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/973969 | Use of oligosaccharides for the treatment of pruritus cutaneus associated with renal failure | Feb 19, 1998 | Issued |
Array
(
[id] => 3949875
[patent_doc_number] => 05977332
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Oligonucleotides having 2\'-ether groups'
[patent_app_type] => 1
[patent_app_number] => 9/026713
[patent_app_country] => US
[patent_app_date] => 1998-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9601
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/977/05977332.pdf
[firstpage_image] =>[orig_patent_app_number] => 026713
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/026713 | Oligonucleotides having 2'-ether groups | Feb 19, 1998 | Issued |
Array
(
[id] => 4077730
[patent_doc_number] => 06017301
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-25
[patent_title] => 'Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions'
[patent_app_type] => 1
[patent_app_number] => 9/023267
[patent_app_country] => US
[patent_app_date] => 1998-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16758
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/017/06017301.pdf
[firstpage_image] =>[orig_patent_app_number] => 023267
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/023267 | Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions | Feb 12, 1998 | Issued |
Array
(
[id] => 4132964
[patent_doc_number] => 06034140
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-07
[patent_title] => 'Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions'
[patent_app_type] => 1
[patent_app_number] => 9/023097
[patent_app_country] => US
[patent_app_date] => 1998-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16771
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/034/06034140.pdf
[firstpage_image] =>[orig_patent_app_number] => 023097
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/023097 | Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions | Feb 12, 1998 | Issued |
| 08/983392 | PHOTOCHEMICALLY CROSS-LINKED POLYSACCHARIDE DERIVATIVES HAVING NO PHOTOPOLYMERISABLE FUNCTIONAL GROUPS | Feb 8, 1998 | Abandoned |
Array
(
[id] => 4144172
[patent_doc_number] => 06063574
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-16
[patent_title] => 'Dioxetane labeled probes and detection assays employing the same'
[patent_app_type] => 1
[patent_app_number] => 9/018180
[patent_app_country] => US
[patent_app_date] => 1998-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7724
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/063/06063574.pdf
[firstpage_image] =>[orig_patent_app_number] => 018180
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/018180 | Dioxetane labeled probes and detection assays employing the same | Feb 2, 1998 | Issued |
Array
(
[id] => 3943581
[patent_doc_number] => 05990094
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-23
[patent_title] => 'Inhibitors of sorotonin N-acetyltransferase'
[patent_app_type] => 1
[patent_app_number] => 9/014340
[patent_app_country] => US
[patent_app_date] => 1998-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 29
[patent_no_of_words] => 16753
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/990/05990094.pdf
[firstpage_image] =>[orig_patent_app_number] => 014340
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/014340 | Inhibitors of sorotonin N-acetyltransferase | Jan 26, 1998 | Issued |
Array
(
[id] => 3907177
[patent_doc_number] => 05898071
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-27
[patent_title] => 'DNA purification and isolation using magnetic particles'
[patent_app_type] => 1
[patent_app_number] => 9/002412
[patent_app_country] => US
[patent_app_date] => 1998-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7110
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/898/05898071.pdf
[firstpage_image] =>[orig_patent_app_number] => 002412
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/002412 | DNA purification and isolation using magnetic particles | Jan 1, 1998 | Issued |